Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 2
2008 3
2009 2
2010 3
2011 4
2012 7
2013 11
2014 5
2015 2
2016 1
2017 3
2018 1
2020 3
2021 3
2022 2
2023 4
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Blind runner.
Pelegrín L, Mesquida M, Rey A, Sánchez-Dalmau B, Frohman L. Pelegrín L, et al. Surv Ophthalmol. 2012 Sep;57(5):486-94. doi: 10.1016/j.survophthal.2011.06.004. Epub 2011 Oct 21. Surv Ophthalmol. 2012. PMID: 22018675
Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study.
Fonollosa A, Pelegrín L, García-Morillo S, Buján-Rivas S, Distefano L, Robles-Maruenda A, Fernández-Martín J, González-García A, Garcia-Aparicio Á, Ortego-Centeno N, Llorenç V, Sainz de la Maza M, Pinedo C, Sopeña B, Cocho L, Carreño E, Blanco R, Antón J, Pérez-Quintana M, Marques-Soares JR, Artaraz J, Ruiz-Arruza I, Soto-Peleteiro A, Gómez-Caverzaschi V, Araújo O, Espinosa G, Adan A, Fabiani C, Cantarini L, Hernández-Rodríguez J; Spanish Society of Ocular Inflammation (SEIOC) and the AutoInflammatory Diseases Alliance (AIDA) Network. Fonollosa A, et al. Among authors: pelegrin l. Clin Exp Rheumatol. 2023 Oct;41(10):2105-2114. doi: 10.55563/clinexprheumatol/ukegcc. Epub 2023 Sep 28. Clin Exp Rheumatol. 2023. PMID: 37812477 Free article.
Oxaliplatin-Related Ocular Toxicity.
Mesquida M, Sanchez-Dalmau B, Ortiz-Perez S, Pelegrín L, Molina-Fernandez JJ, Figueras-Roca M, Casaroli-Marano R, Adán A. Mesquida M, et al. Among authors: pelegrin l. Case Rep Oncol. 2010 Nov 22;3(3):423-427. doi: 10.1159/000322675. Case Rep Oncol. 2010. PMID: 21151636 Free PMC article.
CHARACTERIZING COVID-19-RELATED RETINAL VASCULAR OCCLUSIONS: A Case Series and Review of the Literature.
Fonollosa A, Hernández-Rodríguez J, Cuadros C, Giralt L, Sacristán C, Artaraz J, Pelegrín L, Olate-Pérez Á, Romero R, Pastor-Idoate S, Sobas Bsc EM, Fernández-Fidalgo S, Abraldes MJ, Oleñik A, Insausti-García A, Torres P, Porcar C, Lorca DR, Adan A; Spanish Society of Ocular Inflammation (SEIOC); Spanish Society of Ocular Inflammation (SEIOC). Fonollosa A, et al. Among authors: pelegrin l. Retina. 2022 Mar 1;42(3):465-475. doi: 10.1097/IAE.0000000000003327. Retina. 2022. PMID: 34914345 Review.
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry.
Vitale A, Caggiano V, Martin-Nares E, Frassi M, Dagna L, Hissaria P, Sfriso P, Hernández-Rodríguez J, Ruiz-Irastorza G, Monti S, Tufan A, Piga M, Giardini HAM, Lopalco G, Viapiana O, De Paulis A, Triggianese P, Vitetta R, de-la-Torre A, Fonollosa A, Caroni F, Sota J, Conticini E, Sbalchiero J, Renieri A, Casamassima G, Wiesik-Szewczyk E, Yildirim D, Hinojosa-Azaola A, Crisafulli F, Franceschini F, Campochiaro C, Tomelleri A, Callisto A, Beecher M, Bindoli S, Baggio C, Gómez-Caverzaschi V, Pelegrín L, Soto-Peleteiro A, Milanesi A, Vasi I, Cauli A, Antonelli IPB, Iannone F, Bixio R, Casa FD, Mormile I, Gurnari C, Fiorenza A, Mejia-Salgado G, Kawakami-Campos PA, Ragab G, Ciccia F, Ruscitti P, Bocchia M, Balistreri A, Tosi GM, Frediani B, Cantarini L, Fabiani C. Vitale A, et al. Among authors: pelegrin l. Semin Arthritis Rheum. 2024 Mar 18;66:152430. doi: 10.1016/j.semarthrit.2024.152430. Online ahead of print. Semin Arthritis Rheum. 2024. PMID: 38554594 Free article.
Intravitreal fluocinolone acetonide 0.19 mg (ILUVIEN®) in patients with non-infectious uveitis: real-world effectiveness and safety outcomes at 12 months.
Moll-Udina A, Hernanz I, Sainz-de-la-Maza M, Pelegrín L, Coelho-Borges AI, Pazos M, Adán A, Llorenç V. Moll-Udina A, et al. Among authors: pelegrin l. Int Ophthalmol. 2023 Nov;43(11):4181-4195. doi: 10.1007/s10792-023-02828-6. Epub 2023 Sep 12. Int Ophthalmol. 2023. PMID: 37698661 Free PMC article.
Effectiveness and Safety of Biosimilars in Pediatric Non-infectious Uveitis: Real-Life Data from the International AIDA Network Uveitis Registry.
Tarsia M, Vitale A, Gaggiano C, Sota J, Maselli A, Bellantonio C, Guerriero S, Dammacco R, La Torre F, Ragab G, Hegazy MT, Fonollosa A, Paroli MP, Del Giudice E, Maggio MC, Cattalini M, Fotis L, Conti G, Mauro A, Civino A, Diomeda F, de-la-Torre A, Cifuentes-González C, Tharwat S, Hernández-Rodríguez J, Gómez-Caverzaschi V, Pelegrín L, Babu K, Gupta V, Minoia F, Ruscitti P, Costi S, Breda L, La Bella S, Conforti A, Mazzei MA, Carreño E, Amin RH, Grosso S, Frediani B, Tosi GM, Balistreri A, Cantarini L, Fabiani C. Tarsia M, et al. Among authors: pelegrin l. Ophthalmol Ther. 2024 Mar;13(3):761-774. doi: 10.1007/s40123-023-00863-1. Epub 2024 Jan 11. Ophthalmol Ther. 2024. PMID: 38206518 Free PMC article.
Disease phenotypes in adult patients with suspected undifferentiated autoinflammatory diseases and PFAPA syndrome: Clinical and therapeutic implications.
Gómez-Caverzaschi V, Yagüe J, Espinosa G, Mayordomo-Bofill I, Bedón-Galarza R, Araújo O, Pelegrín L, Arbelo E, Morales X, Balagué O, Figueras-Nart I, Mascaró JM, Fuertes I, Giavedoni P, Muxí A, Alobid I, Vilaseca I, Cervera R, Aróstegui JI, Mensa-Vilaró A, Hernández-Rodríguez J. Gómez-Caverzaschi V, et al. Among authors: pelegrin l. Autoimmun Rev. 2024 Mar 30:103520. doi: 10.1016/j.autrev.2024.103520. Online ahead of print. Autoimmun Rev. 2024. PMID: 38561135 Review.
51 results